Mothers and Newborns Affected by Opioids – Neonatal

64%
55%
88
2.9
In 2018, the Illinois Perinatal Quality Collaborative (ILPQC) launched a statewide initiative to support hospitals in improving care for Opioid-Exposed Newborns (OENs) by implementing American Academy of Pediatrics (AAP) recommended guidelines.
Working with hospital-based teams, ILPQC supported:
- Standardized assessment of Neonatal Abstinence Syndrome (NAS) symptoms (e.g., Eat Sleep Console, Modified Finnegan)
- Engagement of mothers/families in non-pharmacologic care (e.g., rooming-in, breastfeeding)
- Coordinated discharge planning with the care team, family, and pediatrician
These efforts have improved newborn outcomes and reduced unnecessary pharmacologic treatment.
Objectives
- Decrease the proportion of OENs receiving pharmacologic treatment to below 20%
- Increase the proportion of eligible OENs receiving maternal breastmilk to above 70%
- Increase the proportion of OENs discharged with a coordinated discharge plan to above 95%
Reducing Disparities
At the start of the MNO-Neonatal Initiative, Black Opioid Exposed Newborns (OENs) were less likely to have a coordinated discharge compared to White OENs. Across the initiative, improvements in discharge were seen for all OENs with the greatest improvement for Black newborns.
Resources
Our goal is to keep you informed and equipped with evidence-based resources that advance maternal and infant health. We invite you to explore our updates and share in the work of improving outcomes for all families.
Stay engaged. Stay informed. Together, we make care better.